Click to copy
Click to copy

Gilead: 2Q Earnings Snapshot

July 30, 2019

FOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Tuesday reported second-quarter earnings of $1.88 billion.

The Foster City, California-based company said it had profit of $1.47 per share. Earnings, adjusted for costs related to mergers and acquisitions and stock option expense, were $1.82 per share.

The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.74 per share.

The HIV and hepatitis C drugmaker posted revenue of $5.69 billion in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $5.56 billion.

Gilead expects full-year earnings in the range of $3.90 to $4 per share.

Gilead shares have climbed nearly 7% since the beginning of the year, while the Standard & Poor’s 500 index has increased 20%. In the final minutes of trading on Tuesday, shares hit $66.85, a decrease of 12% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD

All contents © copyright 2019 The Associated Press. All rights reserved.